• 00:00 1.
    index 1
  • 00:21 2.
     Introduction
  • 00:56 3.
     Introduction of SEMA5A
  • 00:58 4.
     Introduction
  • 01:01 5.
     Introduction of SEMA5A
  • 02:51 6.
     Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
  • 04:22 7.
     SEMA5A-regulated genes were involved in cell growth and proliferation
  • 05:48 8.
     5A suppressed proliferation in lung cancer cells.
  • 05:58 9.
     SEMA5A-regulated genes were involved in cell growth and proliferation
  • 06:03 10.
     5A suppressed proliferation in lung cancer cells.
  • 07:47 11.
     Lower expression and hypermethylation of 5A in lung cancer cells.
  • 09:08 12.
     Summary of chapter 2
  • 09:37 13.
    銅葉綠素…
  • 13:38 14.
     Introduction of HPLC-PCA
  • 14:57 15.
    Slide 11
  • 15:41 16.
     Chapter 4: Genomic approaches on Chinese medicine concept--- “qi”
  • 18:31 17.
     Internal transcribed spacer (ITS)
  • 18:32 18.
     Chapter 4: Genomic approaches on Chinese medicine concept--- “qi”
  • 18:34 19.
     Internal transcribed spacer (ITS)
  • 19:28 20.
     Viability test of crudes on cancerous cells
  • 19:31 21.
     Internal transcribed spacer (ITS)
  • 19:35 22.
     Viability test of crudes on cancerous cells
  • 20:02 23.
    Slide 15
  • 20:04 24.
     Viability test of crudes on cancerous cells
  • 20:06 25.
    Slide 15
  • 20:23 26.
     Markers identification
  • 21:21 27.
     Markers identification
  • 21:46 28.
     Summary of chapter 3 and 4
  • 22:09 29.
     Chapter : Genomic approaches on a newly synthesized small molecule compound, MCDC
  • 24:13 30.
    Slide 20
  • 25:13 31.
     Synthesis scheme of 1-substituted carbazolyl-1,2,3,4-tetrahydro-β-carboline and carbazolyl-3,4-dihydro-β-carboline derivatives
  • 25:29 32.
    Slide 22
  • 25:59 33.
    Slide 23
  • 28:25 34.
     IC50 of MCDC in A549 and MCF7 cells
  • 29:04 35.
     MIF-MCDC virtual screen-idTarget
  • 30:27 36.
     MIF-MCDC virtual screen-Discovery studio
  • 30:55 37.
     MIF-MCDC in vitro-Hydrogen-deuterium exchange
  • 32:50 38.
     MIF-MCDC in cell line model.
  • 33:19 39.
     MIF-MCDC in cell line model.
  • 33:20 40.
     MIF-MCDC in cell line model.
  • 34:03 41.
     MIF-MCDC in cell line model.
  • 35:30 42.
     MCDC inhibits cell cycle-related protein expression.
  • 36:28 43.
     MCDC inhibits cell cycle-related protein expression.
  • 37:01 44.
     Summary of chapter 5
  • 37:22 45.
     Manual adjustment of HPLC readings
  • 37:26 46.
     Samples not applicable to ITS analysis
  • 37:27 47.
    Slide 35
  • 37:27 48.
     Structures not provided in idTarget
  • 37:28 49.
     Hydrophobicity of MCDC interfered the results of HDX and Biacore.
  • 37:31 50.
     Endogenous MIF expression interfered U251 viability
  • 37:31 51.
    Slide 39
  • 37:31 52.
    Slide 40
  • 37:32 53.
    Slide 39
  • 37:40 54.
     Endogenous MIF expression interfered U251 viability
  • 37:41 55.
     Hydrophobicity of MCDC interfered the results of HDX and Biacore.
  • 37:41 56.
     Structures not provided in idTarget
  • 37:42 57.
    Slide 35
  • 37:42 58.
     Samples not applicable to ITS analysis
  • 37:43 59.
     Manual adjustment of HPLC readings
  • 37:43 60.
     Summary of chapter 5
  • 37:43 61.
     MCDC inhibits cell cycle-related protein expression.
  • 37:44 62.
     MCDC inhibits cell cycle-related protein expression.
  • 37:44 63.
     MIF-MCDC in cell line model.
  • 37:45 64.
     MIF-MCDC in cell line model.
  • 37:45 65.
     MIF-MCDC in vitro-Hydrogen-deuterium exchange
  • 37:46 66.
     MIF-MCDC virtual screen-Discovery studio
  • 37:46 67.
     MIF-MCDC virtual screen-idTarget
  • 37:46 68.
     IC50 of MCDC in A549 and MCF7 cells
  • 37:47 69.
    Slide 23
  • 37:48 70.
    Slide 22
  • 37:48 71.
     Synthesis scheme of 1-substituted carbazolyl-1,2,3,4-tetrahydro-β-carboline and carbazolyl-3,4-dihydro-β-carboline derivatives
  • 37:48 72.
    Slide 20
  • 37:49 73.
     Chapter : Genomic approaches on a newly synthesized small molecule compound, MCDC
  • 37:49 74.
     Summary of chapter 3 and 4
  • 37:50 75.
     Markers identification
  • 37:50 76.
     Markers identification
  • 37:50 77.
    Slide 15
  • 37:51 78.
     Viability test of crudes on cancerous cells
  • 37:51 79.
     Internal transcribed spacer (ITS)
  • 37:52 80.
     Chapter 4: Genomic approaches on Chinese medicine concept--- “qi”
  • 37:52 81.
    Slide 11
  • 37:53 82.
     Introduction of HPLC-PCA
  • 37:53 83.
    銅葉綠素…
  • 37:54 84.
     Summary of chapter 2
  • 37:55 85.
     Lower expression and hypermethylation of 5A in lung cancer cells.
  • 37:57 86.
     5A suppressed proliferation in lung cancer cells.
  • 37:57 87.
     SEMA5A-regulated genes were involved in cell growth and proliferation
  • 37:58 88.
     Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
  • 37:58 89.
     Introduction of SEMA5A
  • 37:59 90.
     Introduction
  • 38:28 91.
     Introduction of SEMA5A
  • 38:31 92.
     Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
  • 38:33 93.
     SEMA5A-regulated genes were involved in cell growth and proliferation
  • 38:37 94.
     5A suppressed proliferation in lung cancer cells.
  • 38:48 95.
     SEMA5A-regulated genes were involved in cell growth and proliferation
  • 38:49 96.
     Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
  • 39:24 97.
     SEMA5A-regulated genes were involved in cell growth and proliferation
  • 39:25 98.
     5A suppressed proliferation in lung cancer cells.
  • 39:25 99.
     Lower expression and hypermethylation of 5A in lung cancer cells.
  • 39:26 100.
     5A suppressed proliferation in lung cancer cells.
  • 40:01 101.
     SEMA5A-regulated genes were involved in cell growth and proliferation
  • 40:01 102.
     Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
  • 40:02 103.
     Introduction of SEMA5A
  • 40:03 104.
     Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
  • 40:43 105.
     SEMA5A-regulated genes were involved in cell growth and proliferation
  • 40:43 106.
     5A suppressed proliferation in lung cancer cells.
  • 42:18 107.
     Lower expression and hypermethylation of 5A in lung cancer cells.
  • 42:19 108.
     5A suppressed proliferation in lung cancer cells.
  • 42:22 109.
     SEMA5A-regulated genes were involved in cell growth and proliferation
  • 42:23 110.
     Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
  • 42:28 111.
     SEMA5A-regulated genes were involved in cell growth and proliferation
  • 42:29 112.
     5A suppressed proliferation in lung cancer cells.
  • 42:30 113.
     Lower expression and hypermethylation of 5A in lung cancer cells.
  • 43:13 114.
     5A suppressed proliferation in lung cancer cells.
  • 44:08 115.
     Lower expression and hypermethylation of 5A in lung cancer cells.
  • 46:03 116.
     5A suppressed proliferation in lung cancer cells.
  • 46:04 117.
     SEMA5A-regulated genes were involved in cell growth and proliferation
  • 46:05 118.
     Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
  • 46:11 119.
     Introduction of SEMA5A
  • 48:37 120.
     Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
  • 48:38 121.
     SEMA5A-regulated genes were involved in cell growth and proliferation
  • 48:38 122.
     5A suppressed proliferation in lung cancer cells.
  • 48:39 123.
     Lower expression and hypermethylation of 5A in lung cancer cells.
  • 48:39 124.
     Summary of chapter 2
  • 50:23 125.
     Lower expression and hypermethylation of 5A in lung cancer cells.
  • 50:24 126.
     Summary of chapter 2
  • 50:24 127.
    銅葉綠素…
  • 50:25 128.
     Introduction of HPLC-PCA
  • 50:25 129.
    Slide 11
  • 50:25 130.
     Introduction of HPLC-PCA
  • 50:26 131.
    銅葉綠素…
  • 50:26 132.
     Summary of chapter 2
  • 50:27 133.
     Lower expression and hypermethylation of 5A in lung cancer cells.
  • 50:27 134.
     5A suppressed proliferation in lung cancer cells.
  • 52:11 135.
     Lower expression and hypermethylation of 5A in lung cancer cells.
  • 52:12 136.
     Summary of chapter 2
  • 52:13 137.
    銅葉綠素…
  • 52:17 138.
     Summary of chapter 2
  • 52:37 139.
    銅葉綠素…
  • 53:40 140.
     Introduction of HPLC-PCA
  • 53:43 141.
    銅葉綠素…
  • 54:57 142.
     Introduction of HPLC-PCA
  • 55:00 143.
    Slide 11
  • 55:03 144.
     Chapter 4: Genomic approaches on Chinese medicine concept--- “qi”
  • 1:01:13 145.
    Slide 11
  • 1:02:41 146.
     Chapter 4: Genomic approaches on Chinese medicine concept--- “qi”
  • 1:04:03 147.
     Internal transcribed spacer (ITS)
  • 1:04:03 148.
     Viability test of crudes on cancerous cells
  • 1:04:04 149.
    Slide 15
  • 1:04:04 150.
     Markers identification
  • 1:04:05 151.
     Markers identification
  • 1:04:05 152.
     Summary of chapter 3 and 4
  • 1:04:06 153.
     Markers identification
  • 1:04:07 154.
     Summary of chapter 3 and 4
  • 1:04:07 155.
     Chapter : Genomic approaches on a newly synthesized small molecule compound, MCDC
  • 1:04:27 156.
    Slide 20
  • 1:07:27 157.
     Synthesis scheme of 1-substituted carbazolyl-1,2,3,4-tetrahydro-β-carboline and carbazolyl-3,4-dihydro-β-carboline derivatives
  • 1:07:28 158.
    Slide 22
  • 1:07:28 159.
    Slide 23
  • 1:07:29 160.
     IC50 of MCDC in A549 and MCF7 cells
  • 1:07:30 161.
     MIF-MCDC virtual screen-idTarget
  • 1:07:31 162.
     MIF-MCDC virtual screen-Discovery studio
  • 1:07:32 163.
     MIF-MCDC in vitro-Hydrogen-deuterium exchange
  • 1:07:32 164.
     MIF-MCDC in cell line model.
  • 1:09:01 165.
     MIF-MCDC in cell line model.
  • 1:09:10 166.
     MIF-MCDC in cell line model.
  • 1:09:48 167.
     MIF-MCDC in cell line model.
  • 1:09:49 168.
     MIF-MCDC in cell line model.
  • 1:09:50 169.
     MIF-MCDC in vitro-Hydrogen-deuterium exchange
  • 1:09:50 170.
     MIF-MCDC virtual screen-Discovery studio
  • 1:09:50 171.
     MIF-MCDC virtual screen-idTarget
  • 1:09:51 172.
     IC50 of MCDC in A549 and MCF7 cells
  • 1:09:59 173.
    Slide 23
  • 1:10:00 174.
    Slide 22
  • 1:10:00 175.
    Slide 23
  • 1:12:09 176.
    Slide 22
  • 1:12:10 177.
     Synthesis scheme of 1-substituted carbazolyl-1,2,3,4-tetrahydro-β-carboline and carbazolyl-3,4-dihydro-β-carboline derivatives
  • 1:12:31 178.
    Slide 20
  • 1:12:33 179.
     Synthesis scheme of 1-substituted carbazolyl-1,2,3,4-tetrahydro-β-carboline and carbazolyl-3,4-dihydro-β-carboline derivatives
  • 1:12:34 180.
    Slide 22
  • 1:12:34 181.
    Slide 23
  • 1:13:25 182.
     IC50 of MCDC in A549 and MCF7 cells
  • 1:13:38 183.
     MIF-MCDC virtual screen-idTarget
  • 1:13:40 184.
     MIF-MCDC virtual screen-Discovery studio
  • 1:13:41 185.
     MIF-MCDC in vitro-Hydrogen-deuterium exchange
  • 1:13:46 186.
     MIF-MCDC in cell line model.
  • 1:13:47 187.
     MIF-MCDC in cell line model.
  • 1:13:47 188.
     MIF-MCDC in cell line model.
  • 1:13:48 189.
     MIF-MCDC in cell line model.
  • 1:13:51 190.
     MCDC inhibits cell cycle-related protein expression.
  • 1:13:52 191.
     MCDC inhibits cell cycle-related protein expression.
  • 1:14:06 192.
     MCDC inhibits cell cycle-related protein expression.
  • 1:15:36 193.
     MIF-MCDC in cell line model.
  • 1:15:36 194.
     MIF-MCDC in cell line model.
  • 1:15:38 195.
     MIF-MCDC in vitro-Hydrogen-deuterium exchange
  • 1:15:39 196.
     MIF-MCDC virtual screen-Discovery studio
  • 1:15:41 197.
     MIF-MCDC virtual screen-idTarget
  • 1:15:41 198.
     IC50 of MCDC in A549 and MCF7 cells
  • 1:15:42 199.
    Slide 23
  • 1:15:52 200.
     IC50 of MCDC in A549 and MCF7 cells
  • 1:15:53 201.
     MIF-MCDC virtual screen-idTarget
  • 1:16:03 202.
     MIF-MCDC virtual screen-Discovery studio
  • 1:16:25 203.
     MIF-MCDC in vitro-Hydrogen-deuterium exchange
  • 1:20:00 204.
    ** after 博論-品豪.pptx
  • Index
  • Notes
  • Comment
  • Fullscreen
20190701-lab meeting_品豪
Duration: 1:20:05, Browse: 602, Last Updated: 2019-07-03
    • 00:00 1.
      index 1
    • 00:21 2.
       Introduction
    • 00:56 3.
       Introduction of SEMA5A
    • 00:58 4.
       Introduction
    • 01:01 5.
       Introduction of SEMA5A
    • 02:51 6.
       Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
    • 04:22 7.
       SEMA5A-regulated genes were involved in cell growth and proliferation
    • 05:48 8.
       5A suppressed proliferation in lung cancer cells.
    • 05:58 9.
       SEMA5A-regulated genes were involved in cell growth and proliferation
    • 06:03 10.
       5A suppressed proliferation in lung cancer cells.
    • 07:47 11.
       Lower expression and hypermethylation of 5A in lung cancer cells.
    • 09:08 12.
       Summary of chapter 2
    • 09:37 13.
      銅葉綠素…
    • 13:38 14.
       Introduction of HPLC-PCA
    • 14:57 15.
      Slide 11
    • 15:41 16.
       Chapter 4: Genomic approaches on Chinese medicine concept--- “qi”
    • 18:31 17.
       Internal transcribed spacer (ITS)
    • 18:32 18.
       Chapter 4: Genomic approaches on Chinese medicine concept--- “qi”
    • 18:34 19.
       Internal transcribed spacer (ITS)
    • 19:28 20.
       Viability test of crudes on cancerous cells
    • 19:31 21.
       Internal transcribed spacer (ITS)
    • 19:35 22.
       Viability test of crudes on cancerous cells
    • 20:02 23.
      Slide 15
    • 20:04 24.
       Viability test of crudes on cancerous cells
    • 20:06 25.
      Slide 15
    • 20:23 26.
       Markers identification
    • 21:21 27.
       Markers identification
    • 21:46 28.
       Summary of chapter 3 and 4
    • 22:09 29.
       Chapter : Genomic approaches on a newly synthesized small molecule compound, MCDC
    • 24:13 30.
      Slide 20
    • 25:13 31.
       Synthesis scheme of 1-substituted carbazolyl-1,2,3,4-tetrahydro-β-carboline and carbazolyl-3,4-dihydro-β-carboline derivatives
    • 25:29 32.
      Slide 22
    • 25:59 33.
      Slide 23
    • 28:25 34.
       IC50 of MCDC in A549 and MCF7 cells
    • 29:04 35.
       MIF-MCDC virtual screen-idTarget
    • 30:27 36.
       MIF-MCDC virtual screen-Discovery studio
    • 30:55 37.
       MIF-MCDC in vitro-Hydrogen-deuterium exchange
    • 32:50 38.
       MIF-MCDC in cell line model.
    • 33:19 39.
       MIF-MCDC in cell line model.
    • 33:20 40.
       MIF-MCDC in cell line model.
    • 34:03 41.
       MIF-MCDC in cell line model.
    • 35:30 42.
       MCDC inhibits cell cycle-related protein expression.
    • 36:28 43.
       MCDC inhibits cell cycle-related protein expression.
    • 37:01 44.
       Summary of chapter 5
    • 37:22 45.
       Manual adjustment of HPLC readings
    • 37:26 46.
       Samples not applicable to ITS analysis
    • 37:27 47.
      Slide 35
    • 37:27 48.
       Structures not provided in idTarget
    • 37:28 49.
       Hydrophobicity of MCDC interfered the results of HDX and Biacore.
    • 37:31 50.
       Endogenous MIF expression interfered U251 viability
    • 37:31 51.
      Slide 39
    • 37:31 52.
      Slide 40
    • 37:32 53.
      Slide 39
    • 37:40 54.
       Endogenous MIF expression interfered U251 viability
    • 37:41 55.
       Hydrophobicity of MCDC interfered the results of HDX and Biacore.
    • 37:41 56.
       Structures not provided in idTarget
    • 37:42 57.
      Slide 35
    • 37:42 58.
       Samples not applicable to ITS analysis
    • 37:43 59.
       Manual adjustment of HPLC readings
    • 37:43 60.
       Summary of chapter 5
    • 37:43 61.
       MCDC inhibits cell cycle-related protein expression.
    • 37:44 62.
       MCDC inhibits cell cycle-related protein expression.
    • 37:44 63.
       MIF-MCDC in cell line model.
    • 37:45 64.
       MIF-MCDC in cell line model.
    • 37:45 65.
       MIF-MCDC in vitro-Hydrogen-deuterium exchange
    • 37:46 66.
       MIF-MCDC virtual screen-Discovery studio
    • 37:46 67.
       MIF-MCDC virtual screen-idTarget
    • 37:46 68.
       IC50 of MCDC in A549 and MCF7 cells
    • 37:47 69.
      Slide 23
    • 37:48 70.
      Slide 22
    • 37:48 71.
       Synthesis scheme of 1-substituted carbazolyl-1,2,3,4-tetrahydro-β-carboline and carbazolyl-3,4-dihydro-β-carboline derivatives
    • 37:48 72.
      Slide 20
    • 37:49 73.
       Chapter : Genomic approaches on a newly synthesized small molecule compound, MCDC
    • 37:49 74.
       Summary of chapter 3 and 4
    • 37:50 75.
       Markers identification
    • 37:50 76.
       Markers identification
    • 37:50 77.
      Slide 15
    • 37:51 78.
       Viability test of crudes on cancerous cells
    • 37:51 79.
       Internal transcribed spacer (ITS)
    • 37:52 80.
       Chapter 4: Genomic approaches on Chinese medicine concept--- “qi”
    • 37:52 81.
      Slide 11
    • 37:53 82.
       Introduction of HPLC-PCA
    • 37:53 83.
      銅葉綠素…
    • 37:54 84.
       Summary of chapter 2
    • 37:55 85.
       Lower expression and hypermethylation of 5A in lung cancer cells.
    • 37:57 86.
       5A suppressed proliferation in lung cancer cells.
    • 37:57 87.
       SEMA5A-regulated genes were involved in cell growth and proliferation
    • 37:58 88.
       Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
    • 37:58 89.
       Introduction of SEMA5A
    • 37:59 90.
       Introduction
    • 38:28 91.
       Introduction of SEMA5A
    • 38:31 92.
       Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
    • 38:33 93.
       SEMA5A-regulated genes were involved in cell growth and proliferation
    • 38:37 94.
       5A suppressed proliferation in lung cancer cells.
    • 38:48 95.
       SEMA5A-regulated genes were involved in cell growth and proliferation
    • 38:49 96.
       Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
    • 39:24 97.
       SEMA5A-regulated genes were involved in cell growth and proliferation
    • 39:25 98.
       5A suppressed proliferation in lung cancer cells.
    • 39:25 99.
       Lower expression and hypermethylation of 5A in lung cancer cells.
    • 39:26 100.
       5A suppressed proliferation in lung cancer cells.
    • 40:01 101.
       SEMA5A-regulated genes were involved in cell growth and proliferation
    • 40:01 102.
       Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
    • 40:02 103.
       Introduction of SEMA5A
    • 40:03 104.
       Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
    • 40:43 105.
       SEMA5A-regulated genes were involved in cell growth and proliferation
    • 40:43 106.
       5A suppressed proliferation in lung cancer cells.
    • 42:18 107.
       Lower expression and hypermethylation of 5A in lung cancer cells.
    • 42:19 108.
       5A suppressed proliferation in lung cancer cells.
    • 42:22 109.
       SEMA5A-regulated genes were involved in cell growth and proliferation
    • 42:23 110.
       Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
    • 42:28 111.
       SEMA5A-regulated genes were involved in cell growth and proliferation
    • 42:29 112.
       5A suppressed proliferation in lung cancer cells.
    • 42:30 113.
       Lower expression and hypermethylation of 5A in lung cancer cells.
    • 43:13 114.
       5A suppressed proliferation in lung cancer cells.
    • 44:08 115.
       Lower expression and hypermethylation of 5A in lung cancer cells.
    • 46:03 116.
       5A suppressed proliferation in lung cancer cells.
    • 46:04 117.
       SEMA5A-regulated genes were involved in cell growth and proliferation
    • 46:05 118.
       Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
    • 46:11 119.
       Introduction of SEMA5A
    • 48:37 120.
       Down-regulation of SEMA5A in lung adenocarcinoma tissues and cell lines
    • 48:38 121.
       SEMA5A-regulated genes were involved in cell growth and proliferation
    • 48:38 122.
       5A suppressed proliferation in lung cancer cells.
    • 48:39 123.
       Lower expression and hypermethylation of 5A in lung cancer cells.
    • 48:39 124.
       Summary of chapter 2
    • 50:23 125.
       Lower expression and hypermethylation of 5A in lung cancer cells.
    • 50:24 126.
       Summary of chapter 2
    • 50:24 127.
      銅葉綠素…
    • 50:25 128.
       Introduction of HPLC-PCA
    • 50:25 129.
      Slide 11
    • 50:25 130.
       Introduction of HPLC-PCA
    • 50:26 131.
      銅葉綠素…
    • 50:26 132.
       Summary of chapter 2
    • 50:27 133.
       Lower expression and hypermethylation of 5A in lung cancer cells.
    • 50:27 134.
       5A suppressed proliferation in lung cancer cells.
    • 52:11 135.
       Lower expression and hypermethylation of 5A in lung cancer cells.
    • 52:12 136.
       Summary of chapter 2
    • 52:13 137.
      銅葉綠素…
    • 52:17 138.
       Summary of chapter 2
    • 52:37 139.
      銅葉綠素…
    • 53:40 140.
       Introduction of HPLC-PCA
    • 53:43 141.
      銅葉綠素…
    • 54:57 142.
       Introduction of HPLC-PCA
    • 55:00 143.
      Slide 11
    • 55:03 144.
       Chapter 4: Genomic approaches on Chinese medicine concept--- “qi”
    • 1:01:13 145.
      Slide 11
    • 1:02:41 146.
       Chapter 4: Genomic approaches on Chinese medicine concept--- “qi”
    • 1:04:03 147.
       Internal transcribed spacer (ITS)
    • 1:04:03 148.
       Viability test of crudes on cancerous cells
    • 1:04:04 149.
      Slide 15
    • 1:04:04 150.
       Markers identification
    • 1:04:05 151.
       Markers identification
    • 1:04:05 152.
       Summary of chapter 3 and 4
    • 1:04:06 153.
       Markers identification
    • 1:04:07 154.
       Summary of chapter 3 and 4
    • 1:04:07 155.
       Chapter : Genomic approaches on a newly synthesized small molecule compound, MCDC
    • 1:04:27 156.
      Slide 20
    • 1:07:27 157.
       Synthesis scheme of 1-substituted carbazolyl-1,2,3,4-tetrahydro-β-carboline and carbazolyl-3,4-dihydro-β-carboline derivatives
    • 1:07:28 158.
      Slide 22
    • 1:07:28 159.
      Slide 23
    • 1:07:29 160.
       IC50 of MCDC in A549 and MCF7 cells
    • 1:07:30 161.
       MIF-MCDC virtual screen-idTarget
    • 1:07:31 162.
       MIF-MCDC virtual screen-Discovery studio
    • 1:07:32 163.
       MIF-MCDC in vitro-Hydrogen-deuterium exchange
    • 1:07:32 164.
       MIF-MCDC in cell line model.
    • 1:09:01 165.
       MIF-MCDC in cell line model.
    • 1:09:10 166.
       MIF-MCDC in cell line model.
    • 1:09:48 167.
       MIF-MCDC in cell line model.
    • 1:09:49 168.
       MIF-MCDC in cell line model.
    • 1:09:50 169.
       MIF-MCDC in vitro-Hydrogen-deuterium exchange
    • 1:09:50 170.
       MIF-MCDC virtual screen-Discovery studio
    • 1:09:50 171.
       MIF-MCDC virtual screen-idTarget
    • 1:09:51 172.
       IC50 of MCDC in A549 and MCF7 cells
    • 1:09:59 173.
      Slide 23
    • 1:10:00 174.
      Slide 22
    • 1:10:00 175.
      Slide 23
    • 1:12:09 176.
      Slide 22
    • 1:12:10 177.
       Synthesis scheme of 1-substituted carbazolyl-1,2,3,4-tetrahydro-β-carboline and carbazolyl-3,4-dihydro-β-carboline derivatives
    • 1:12:31 178.
      Slide 20
    • 1:12:33 179.
       Synthesis scheme of 1-substituted carbazolyl-1,2,3,4-tetrahydro-β-carboline and carbazolyl-3,4-dihydro-β-carboline derivatives
    • 1:12:34 180.
      Slide 22
    • 1:12:34 181.
      Slide 23
    • 1:13:25 182.
       IC50 of MCDC in A549 and MCF7 cells
    • 1:13:38 183.
       MIF-MCDC virtual screen-idTarget
    • 1:13:40 184.
       MIF-MCDC virtual screen-Discovery studio
    • 1:13:41 185.
       MIF-MCDC in vitro-Hydrogen-deuterium exchange
    • 1:13:46 186.
       MIF-MCDC in cell line model.
    • 1:13:47 187.
       MIF-MCDC in cell line model.
    • 1:13:47 188.
       MIF-MCDC in cell line model.
    • 1:13:48 189.
       MIF-MCDC in cell line model.
    • 1:13:51 190.
       MCDC inhibits cell cycle-related protein expression.
    • 1:13:52 191.
       MCDC inhibits cell cycle-related protein expression.
    • 1:14:06 192.
       MCDC inhibits cell cycle-related protein expression.
    • 1:15:36 193.
       MIF-MCDC in cell line model.
    • 1:15:36 194.
       MIF-MCDC in cell line model.
    • 1:15:38 195.
       MIF-MCDC in vitro-Hydrogen-deuterium exchange
    • 1:15:39 196.
       MIF-MCDC virtual screen-Discovery studio
    • 1:15:41 197.
       MIF-MCDC virtual screen-idTarget
    • 1:15:41 198.
       IC50 of MCDC in A549 and MCF7 cells
    • 1:15:42 199.
      Slide 23
    • 1:15:52 200.
       IC50 of MCDC in A549 and MCF7 cells
    • 1:15:53 201.
       MIF-MCDC virtual screen-idTarget
    • 1:16:03 202.
       MIF-MCDC virtual screen-Discovery studio
    • 1:16:25 203.
       MIF-MCDC in vitro-Hydrogen-deuterium exchange
    • 1:20:00 204.
      ** after 博論-品豪.pptx
    Location
    Folder name
    2019
    Author
    李冠儀
    Branch
    賴亮全教授
    Created
    2019-07-03 12:08:14
    Last Updated
    2019-07-03 14:15:26
    Duration
    1:20:05